Header Logo

Connection

Astrid Manuel to Leukotriene Antagonists

Back to Details
This is a "connection" page, showing publications Astrid Manuel has written about Leukotriene Antagonists.
Astrid Manuel
Connection Strength
0.959
Leukotriene Antagonists
  1. Montelukast as a repurposable additive drug for standard-efficacy multiple sclerosis treatment: Emulating clinical trials with retrospective administrative health claims data. Mult Scler. 2024 May; 30(6):696-706.
    View in: PubMed
    Score: 0.959
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.